As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Cancer Pathophysiology”, which are listed below:
1. “From Genes to Clinical Practice: Exploring the Genomic Underpinnings of Endometrial Cancer”
by Thulo Molefi, Lloyd Mabonga, Rodney Hull, Motshedisi Sebitloane and Zodwa Dlamini
Cancers 2025, 17(2), 320; https://doi.org/10.3390/cancers17020320
Available online: https://www.mdpi.com/2072-6694/17/2/320
2. “Translational Advances in Oncogene and Tumor-Suppressor Gene Research”
by Radoslav Stojchevski, Edward Agus Sutanto, Rinni Sutanto, Nikola Hadzi-Petrushev, Mitko Mladenov, Sajal Raj Singh, Jitendra Kumar Sinha, Shampa Ghosh, Bhuvaneshwar Yarlagadda, Krishna Kumar Singh et al.
Cancers 2025, 17(6), 1008; https://doi.org/10.3390/cancers17061008
Available online: https://www.mdpi.com/2072-6694/17/6/1008
3. “The Gut–Endometrium Axis: Exploring the Role of Microbiome in the Pathogenesis and Treatment of Endometrial Cancer—A Narrative Review”
by Beibei Zhang, Nur Fatin Nabilah Mohd Sahardi, Wen Di, Xiaoran Long and Mohamad Nasir Shafiee
Cancers 2025, 17(6), 1044; https://doi.org/10.3390/cancers17061044
Available online: https://www.mdpi.com/2072-6694/17/6/1044
4. “Sexual-Sparing Radical Cystectomy in the Robot-Assisted Era: A Review on Functional and Oncological Outcomes”
by Carlo Introini, Manfredi Bruno Sequi, Marco Ennas, Andrea Benelli, Giovanni Guano, Antonio Luigi Pastore and Antonio Carbone
Cancers 2025, 17(1), 110; https://doi.org/10.3390/cancers17010110
Available online: https://www.mdpi.com/2072-6694/17/1/110
5. “Unique Molecular Alteration of Lobular Breast Cancer: Association with Pathological Classification, Tumor Biology and Behavior, and Clinical Management”
by Huina Zhang and Yan Peng
Cancers 2025, 17(3), 417; https://doi.org/10.3390/cancers17030417
Available online: https://www.mdpi.com/2072-6694/17/3/417
6. “Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations”
by Ersin Karatayli, Shifana C. Sadiq,örn M. Schattenberg, Stephan Grabbe, Bernhard Biersack and Leonard Kaps
Cancers 2025, 17(3), 484; https://doi.org/10.3390/cancers17030484
Available online: https://www.mdpi.com/2072-6694/17/3/484
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
